Articles

Why Nvidia’s stock isn’t partying like other parts of the chip sector this year

Nvidia’s stock is lagging semiconductor peers in the wake of TSM earnings — underscoring both its well-trodden narrative and the self-reinforcing outperformance of memory stocks.

Inflation relief is on the way — if these 3 market forces can come together this year

Productivity gains, tame oil prices and lower taxes could ease the pressure on consumers.

Mortgage rates fall to lowest level in over 3 years as home-buying activity picks up

It’s a major shift from where rates were a year ago: Last January, the 30-year rate averaged 7.04%.

Gen Z men believe they’ll buy a home someday — but see their finances getting worse. What gives?

Homeownership, marriage and parenthood are highly valued goals — and a tall order in today’s economy.

Why Rocket Lab’s stock could cool off after a blistering 263% rally in the past year

Rocket Lab’s stock price already reflects the impact of major recent milestones and renewed enthusiasm for the space sector, a KeyBanc analyst argues.

Half of GLP-1 users ditch their injections — and some are turning to other weight-loss methods instead

New research has found that 50% of patients regain the weight they lost if they stop taking Wegovy and Zepbound

These under-the-radar stocks combine fast growth with big upside potential

The companies are projected to grow sales rapidly through 2027, and many of the stocks are expected to show double-digit increases this year.

Amazon’s stock could face this sneaky AI risk

Some on Wall Street think agentic commerce could help Amazon’s business, but a Raymond James analyst worries the trend could eat into the company’s dominance.

Banks were the sector be in last year — and may be in 2026, too, says JPMorgan

The end of the era of interest-rate repression across most major economies has benefited banks immensely.

Jobless claims – aka layoffs – fall below 200,000. Labor market shows signs of bottoming out.

The number of Americans who applied for unemployment benefits fell in early January to a 1 1/2-month low and dropped below the key 200,000 threshold for only the second time in a year, possibly a sign of improvement in a frail U.S. labor market.

Goldman Sachs’ revenue fell for first time in 2 years — Apple Card was the problem

Goldman Sachs beat fourth-quarter profit expectations by a wide margin, amid particular strength in the investment banking and equities businesses, but the stock fell as revenue disappointed.

Boston Scientific is buying Penumbra for $14.5 billion, gaining entry to ‘fast-growing’ vascular segments

Penumbra’s stock was up about 14% after the deal was announced Thursday morning.
1 15 16 17 18 19 2,553